Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: Analysis of 515 patients

Rheumatology (United Kingdom)

Volumn 55, Issue 8, 2016, Pages 1443-1451

  Retamozo, Soledad ^a   Gheitasi, Hoda ^a   Quartuccio, Luca ^b   Kostov, Belchin ^a,c   Corazza, Laura ^b   Bové, Albert ^a   Sisó Almirall, Antoni ^c   Gandía, Myriam ^a   Ramos Casals, Manuel ^a   De Vita, Salvatore ^b   Brito Zerón, Pilar ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Cryoglobulinaemia; ESSDAI; Mortality; Sj gren syndrome; Vasculitis

Indexed keywords

CRYOGLOBULIN;

ADULT; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; CRYOGLOBULINAEMIC VASCULITIS; CRYOGLOBULINEMIA; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTION; PRIORITY JOURNAL; SJOEGREN SYNDROME; VASCULITIS; CLINICAL TRIAL; COMPLICATION; KAPLAN MEIER METHOD; LYMPHOMA, B-CELL; MULTICENTER STUDY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC VASCULITIS;

CRYOGLOBULINEMIA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SJOGREN'S SYNDROME; SYSTEMIC VASCULITIS;

EID: 84988646141     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew194     Document Type: Article

References (27)

1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ 2012;344:e3821.
2. Brito-Zeron P, Ramos-Casals M. Advances in the understanding and treatment of systemic complications in Sjögren syndrome. Curr Opin Rheumatol 2014;26:520-7.
3. Seror R, Theander E, Bootsma H et al. Outcome measures for primary Sjögren's syndrome: a comprehensive review. J Autoimmun 2014;51:51-6.
4. Ramos-Casals M, Brito-Zerón P, Solans R et al. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology 2014;53:321-31.
5. Seror R, Theander E, Brun JG et al. Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015;74:859-66.
6. Baldini C, Pepe P, Quartuccio L et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 2014;53:839-44.
7. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012;379:348-60.
8. Ramos-Casals M, Brito-Zerón P, Bové A, Sisó A. Sjögren's syndrome: beyond sicca involvement. In: Khamashta MA, Ramos-Casals M, eds. Autoimmune Diseases. Acute and Complex Situations. London: Springer, 2011, 45-66.
9. De Vita S, Soldano F, Isola M et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis 2011;70:1183-90.
10. Quartuccio L, Isola M, Corazza L et al. Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology 2014;53:2209-13.
11. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
12. Ramos-Casals M, Cervera R, Yagüe J et al. Cryoglobulinemia in primary Sjögren's syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 1998;28:200-5.
13. Zaja F, De Vita S, Mazzaro C et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003;101:3827-34.
14. Swerdlow SH, Campo E, Harris NL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. Lyon: WHO, 2008.
15. Brito-Zerón P, Kostov B, Solans R et al. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis 2014;75:348-55.
16. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 2005;4:8-15.
17. Quartuccio L, Isola M, Corazza L et al. Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virusunrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol 2012;30:S48-52.
18. Brito-Zerón P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology 2007;46:1359-62.
19. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
20. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262-9.
21. Quartuccio L, Isola M, Baldini C et al. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun 2014;51:75-80.
22. Quartuccio L, Isola M, Baldini C et al. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. Scand J Rheumatol 2015;44:36-41.
23. Brito-Zerón P, Retamozo S, Gandía M et al. Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes. J Autoimmun 2012;39:43-8.
24. Papageorgiou A, Ziogas DC, Mavragani CP et al. Predicting the outcome of Sjogren's syndrome-associated non-Hodgkin's lymphoma patients. PLoS One 2015;10:e0116189.
25. Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 2015;168:317-27.
26. Routsias JG, Goules JD, Charalampakis G et al. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 2013;43:178-86.
27. Liang Y, Yang Z, Qin B, Zhong R. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis 2014;73:1151-6.